Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.11, $0.03 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $153.4 million versus the consensus estimate of $146.91 million.

Alkermes sees FY2014 EPS of $0.19-$0.32, versus prior guidance of $0.41-$0.54 and the consensus of $0.49.

For earnings history and earnings-related data on Alkermes (ALKS) click here.